White matter hyperintensities do not impact cognitive function in patients with newly diagnosed Parkinson's disease

NeuroImage

Volumn 47, Issue 4, 2009, Pages 2083-2089

  Dalaker, Turi O ^a,b,c   Larsen, Jan P ^b,c,d   Dwyer, Michael G ^a   Aarsland, Dag ^c,d   Beyer, Mona K ^b,c   Alves, Guido ^b,c   Bronnick, Kolbjorn ^c   Tysnes, Ole Bjorn ^d,e   Zivadinov, Robert ^a,f  

^a UNIVERSITY AT BUFFALO   (United States)

^b STAVANGER UNIVERSITY HOSPITAL   (Norway)

^c Norwegian Centre for Movement Disorders   (Norway)

^d UNIVERSITY OF BERGEN   (Norway)

^e HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^f JACOBS NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Magnetic resonance imaging; Mild cognitive impairment; Parkinson's disease; White matter hyperintensities

Indexed keywords

AGE; AGED; ARTICLE; ATTENTION; BRAIN FUNCTION; BRAIN SIZE; COGNITION; CONTROLLED STUDY; DEPTH PERCEPTION; DISEASE ASSOCIATION; DISEASE DURATION; EDUCATIONAL STATUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY CONSOLIDATION; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROBABILITY; SCORING SYSTEM; SEX DIFFERENCE; WHITE MATTER;

AGED; BRAIN; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; PARKINSON DISEASE;

EID: 67651017515     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2009.06.020     Document Type: Article

References (44)

1. Aarsland D., Perry R., Brown A., Larsen J.P., and Ballard C. Neuropathology of dementia in Parkinson's disease: a prospective, community-based study. Ann. Neurol. 58 (2005) 773-776
2. Aarsland D., Bronnick K., Larsen J.P., Tysnes O.B., and Alves G. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study. Neurology (2008)
3. Allcock L.M., Ullyart K., Kenny R.A., and Burn D.J. Frequency of orthostatic hypotension in a community based cohort of patients with Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 75 (2004) 1470-1471
4. Alves G., Muller B., Herlofson K., HogenEsch I., Telstad W., Aarsland D., Tysnes O.B., and Larsen J.P. Incidence of Parkinson's disease in Norway. The Norwegian ParkWest study. J. Neurol. Neurosurg. Psychiatry (2009)
5. Au R., Massaro J.M., Wolf P.A., Young M.E., Beiser A., Seshadri S., D'Agostino R.B., and DeCarli C. Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch. Neurol. 63 (2006) 246-250
6. Ballard C., O'Brien J., Barber B., Scheltens P., Shaw F., McKeith I., and Kenny R.A. Neurocardiovascular instability, hypotensive episodes, and MRI lesions in neurodegenerative dementia. Ann. N.Y. Acad. Sci. 903 (2000) 442-445
7. Barber R., Scheltens P., Gholkar A., Ballard C., McKeith I., Ince P., Perry R., and O'Brien J. White matter lesions on magnetic resonance imaging in dementia with Lewy bodies, Alzheimer's disease, vascular dementia, and normal aging. J. Neurol. Neurosurg. Psychiatry 67 (1999) 66-72
8. Beyer M.K., Aarsland D., Greve O.J., and Larsen J.P. Visual rating of white matter hyperintensities in Parkinson's disease. Mov. Disord. 21 (2006) 223-229
9. Beyer M.K., Janvin C.C., Larsen J.P., and Aarsland D. A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J. Neurol. Neurosurg. Psychiatry 78 (2007) 254-259
10. Bohnen N.I., and Frey K.A. Imaging of cholinergic and monoaminergic neurochemical changes in neurodegenerative disorders. Mol. Imaging Biol. 9 (2007) 243-257
11. Bombois S., Debette S., Delbeuck X., Bruandet A., Lepoittevin S., Delmaire C., Leys D., and Pasquier F. Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment subtypes. Stroke 38 (2007) 2595-2597
12. Burton E.J., Kenny R.A., O'Brien J., Stephens S., Bradbury M., Rowan E., Kalaria R., Firbank M., Wesnes K., and Ballard C. White matter hyperintensities are associated with impairment of memory, attention, and global cognitive performance in older stroke patients. Stroke 35 (2004) 1270-1275
13. Burton E.J., McKeith I.G., Burn D.J., Firbank M.J., and O'Brien J.T. Progression of white matter hyperintensities in Alzheimer disease, dementia with Lewy bodies, and Parkinson disease dementia: a comparison with normal aging. Am. J. Geriatr. Psychiatry 14 (2006) 842-849
14. de Leeuw F.E., de Groot J.C., Achten E., Oudkerk M., Ramos L.M., Heijboer R., Hofman A., Jolles J., van Gijn J., and Breteler M.M. Prevalence of cerebral white matter lesions in elderly people: a population based magnetic resonance imaging study. The Rotterdam Scan Study. J. Neurol. Neurosurg. Psychiatry 70 (2001) 9-14
15. Emre M., Aarsland D., Brown R., Burn D.J., Duyckaerts C., Mizuno Y., Broe G.A., Cummings J., Dickson D.W., Gauthier S., Goldman J., Goetz C., Korczyn A., Lees A., Levy R., Litvan I., McKeith I., Olanow W., Poewe W., Quinn N., Sampaio C., Tolosa E., and Dubois B. Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov. Disord. 22 (2007) 1689-1707 quiz 1837
16. Fahn S., Elton R., and Marsden C. Unified Parkinson's disease rating scale. In: Fahn S., Marsden C., Goldstein M., and Calne D. (Eds). Recent Developments in Parkinson's Disease (1987), McMillan Healthcare Information, Florham Park, NJ 153-163
17. Fazekas F. Magnetic resonance signal abnormalities in asymptomatic individuals: their incidence and functional correlates. Eur. Neurol. 29 (1989) 164-168
18. Folstein M.F., Folstein S.E., and McHugh P.R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr Res. 12 (1975) 189-198
19. Foltynie T., Brayne C.E., Robbins T.W., and Barker R.A. The cognitive ability of an incident cohort of Parkinson's patients in the UK. The CamPaIGN study. Brain 127 (2004) 550-560
20. Gelb D.J., Oliver E., and Gilman S. Diagnostic criteria for Parkinson disease. Arch. Neurol. 56 (1999) 33-39
21. Golden C.J. The identification of brain damage by an abbreviated form of the Halstead-Reitan Neuropsychological Battery. J. Clin. Psychol. 32 (1976) 821-826
22. Haugarvoll K., Aarsland D., Wentzel-Larsen T., and Larsen J.P. The influence of cerebrovascular risk factors on incident dementia in patients with Parkinson's disease. Acta Neurol. Scand. 112 (2005) 386-390
23. Hoehn M.M., and Yahr M.D. Parkinsonism: onset, progression and mortality. Neurology 17 (1967) 427-442
24. Janvin C.C., Larsen J.P., Aarsland D., and Hugdahl K. Subtypes of mild cognitive impairment in Parkinson's disease: progression to dementia. Mov. Disord. 21 (2006) 1343-1349
25. Jellinger K.A. Prevalence of cerebrovascular lesions in Parkinson's disease. A postmortem study. Acta Neuropathol. 105 (2003) 415-419
26. Jorm A.F. The Informant Questionnaire on cognitive decline in the elderly (IQCODE): a review. Int. Psychogeriatr. 16 (2004) 275-293
27. Leentjens A.F., Verhey F.R., Lousberg R., Spitsbergen H., and Wilmink F.W. The validity of the Hamilton and Montgomery-Asberg depression rating scales as screening and diagnostic tools for depression in Parkinson's disease. Int. J. Geriatr. Psychiatry 15 (2000) 644-649
28. Liao D., Cooper L., Cai J., Toole J., Bryan N., Burke G., Shahar E., Nieto J., Mosley T., and Heiss G. The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study. Neuroepidemiology 16 (1997) 149-162
29. Marshall G.A., Shchelchkov E., Kaufer D.I., Ivanco L.S., and Bohnen N.I. White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia. Acta Neurol. Scand. 113 (2006) 87-91
30. Meyer J.S., Huang J., and Chowdhury M.H. MRI confirms mild cognitive impairments prodromal for Alzheimer's, vascular and Parkinson-Lewy body dementias. J. Neurol. Sci. 257 (2007) 97-104
31. Montgomery S.A., and Asberg M. A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979) 382-389
32. Nichols T.E., and Holmes A.P. Nonparametric permutation tests for functional neuroimaging: a primer with examples. Hum. Brain Mapp. 15 (2002) 1-25
33. Oosterman J.M., van Harten B., Weinstein H.C., Scheltens P., Sergeant J.A., and Scherder E.J. White matter hyperintensities and working memory: an explorative study. Neuropsychol. Dev. Cogn. B Aging Neuropsychol. Cogn. 15 (2008) 384-399
34. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Intern. Med. 256 (2004) 183-194
35. Scigliano G., Musicco M., Soliveri P., Piccolo I., Ronchetti G., and Girotti F. Reduced risk factors for vascular disorders in Parkinson disease patients: a case-control study. Stroke 37 (2006) 1184-1188
36. Smith S.M., and Nichols T.E. Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. NeuroImage 44 (2009) 83-98
37. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., and Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. NeuroImage 23 Suppl. 1 (2004) S208-S219
38. Tullberg M., Fletcher E., DeCarli C., Mungas D., Reed B.R., Harvey D.J., Weiner M.W., Chui H.C., and Jagust W.J. White matter lesions impair frontal lobe function regardless of their location. Neurology 63 (2004) 246-253
39. van de Pol L.A., Korf E.S., van der Flier W.M., Brashear H.R., Fox N.C., Barkhof F., and Scheltens P. Magnetic resonance imaging predictors of cognition in mild cognitive impairment. Arch. Neurol. 64 (2007) 1023-1028
40. van Straaten E.C., Fazekas F., Rostrup E., Scheltens P., Schmidt R., Pantoni L., Inzitari D., Waldemar G., Erkinjuntti T., Mantyla R., Wahlund L.O., and Barkhof F. Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study. Stroke 37 (2006) 836-840
41. Warrington E.K., and James M. A new test of object decision: 2D silhouettes featuring a minimal view. Cortex 27 (1991) 370-383
42. Woods S.P., Delis D.C., Scott J.C., Kramer J.H., and Holdnack J.A. The California verbal learning test-second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms. Arch. Clin. Neuropsychol. 21 (2006) 413-420
43. Young V.G., Halliday G.M., and Kril J.J. Neuropathologic correlates of white matter hyperintensities. Neurology (2008)
44. Zivadinov R., Rudick R.A., De Masi R., Nasuelli D., Ukmar M., Pozzi-Mucelli R.S., Grop A., Cazzato G., and Zorzon M. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 57 (2001) 1239-1247